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SUMMARY
Interleukin-1 receptor associated kinases (IRAKs) are key players in innate immune signaling that mediate the
host response to pathogens. In contrast to the active kinases IRAK1 and IRAK4, IRAK2 and IRAK3 are pseu-
dokinases lacking catalytic activity and their functions are poorly understood. IRAK3 is thought to be a nega-
tive regulator of innate immune signaling and mutations in IRAK3 are associated with asthma and cancer.
Here, we report the crystal structure of the human IRAK3 pseudokinase domain in a closed, pseudoactive
conformation. IRAK3 dimerizes in a unique way through a head-to-head arrangement not observed in any
other kinases. Multiple conserved cysteine residues imply a potential redox control of IRAK3 conformation
and dimerization. By analyzing asthma-associated mutations, we identify an evolutionarily conserved sur-
face on IRAK3 that could form an interaction interface with IRAK4, suggesting a model for the negative regu-
lation of IRAK4 by IRAK3.
INTRODUCTION
The innate immune system is the first line of defense against bac-
teria, viruses and parasites. Molecules associated with invading
pathogens are recognized by pattern recognition receptors,
such as Toll-like receptors (TLRs), initiating a rapid response
(Kimbrell and Beutler, 2001). Engaged TLRs recruit the adaptor
protein MyD88 (myeloid differentiation primary response protein
88) that serves as an assembly platform formembers of the inter-
leukin-1 receptor associated kinase (IRAK) family to form an olig-
omeric signaling complex called the Myddosome (Motshwene
et al., 2009; Lin et al., 2010). Myddosome assembly initiates
downstream signaling cascades that trigger the expression
and secretion of pro-inflammatory and anti-inflammatory media-
tors to shape the immune response to pathogens (Winston et al.,
1999; Dumitru et al., 2000; Kanayama et al., 2004; Xia et al.,
2009; Pauls et al., 2012; Lopez-Pelaez et al., 2014; Cohen and
Strickson, 2017).
In humans, the IRAK family of kinases consists of four mem-
bers that share a similar domain architecture (Figure 1A). All
IRAKs have N-terminal death domains (DDs) of 100 amino
acids that facilitate oligomerization with the DDs of MyD88 mol-
ecules to form the Myddosome (Feinstein et al., 1995; Motsh-
wene et al., 2009). The DDs are followed by stretches of 40 to
100 amino acids rich in proline, serine and threonine residues
(PST regions) that undergo hyperphosphorylation during innate
immune signaling (Kollewe et al., 2004). The PST region is fol-
lowed by the respective kinase or pseudokinase domains, and
three of the four IRAK family members, IRAKs-1, -2 and -3,
have an additional C-terminal domain that contains conserved
TRAF6-binding motifs (Ye et al., 2002).
Eukaryotic protein kinases have a common structural fold,
consisting of a b-strand-rich N-lobe and a mostly a-helical C-
lobe (Taylor and Radzio-Andzelm, 1994) with the ATP-binding
pocket and key catalytic residues located between the two
lobes. Most canonical protein kinases can switch between a
catalytically productive, closed conformation and an unproduc-
tive, open conformation. Hallmarks of an active kinase confor-
mation include an inward-oriented aC-helix, the assembly of a
hydrophobic regulatory spine (R-spine) and an inward-position
of the DFG-motif residues (Kornev et al., 2006; Taylor and Kor-
nev, 2011; Modi and Dunbrack, 2019).
Eukaryotic protein kinases share canonical active site motifs
that fulfill critical roles in ATP-binding, Mg2+-binding and catal-
ysis of the phospho-transfer reaction (Hanks et al., 1988; Zheng
et al., 1993; Taylor and Radzio-Andzelm, 1994; Johnson et al.,
1996; Scheeff et al., 2009). The glycine-rich G-loop with the
conserved ‘‘[G/A/S]xGxx[G/A/S]’’ sequence motif assists in
ATP-binding, while the KE-salt bridge, formed by K72 and E91
in the canonical cAMP-dependent protein kinase catalytic sub-
unit a (PKA), stabilizes the closed, active kinase conformation
and positions the lysine for binding of the a-phosphate of ATP.
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The catalytic ‘‘[H/Y]RD’’-motif harbors a critical aspartate resi-
due that primes the hydroxyl-group of the substrate for nucleo-
philic attack on the g-phosphate of ATP. A second conserved
aspartate residue in the ‘‘DFG’’-motif binds to Mg2+-ions of
Mg-ATP, positioning and polarizing the g-phosphate of ATP for
efficient transfer onto substrates.
Interestingly, about 10% of the proteins in the human kinome
lack one or more critical residues that are required for ATP-bind-
ing or for catalysis of the phosphoryl-transfer reaction and are
therefore referred to as pseudokinases (Manning et al., 2002;
Boudeau et al., 2006; Ribeiro et al., 2019). Detailed examination
of individual pseudokinases revealed that they often function as
crucial components of cell signaling pathways through unique
and novel mechanisms. Pseudokinases can be broadly catego-
rized into three types that (1) retain their catalytic activity by
compensatory mechanisms (e.g., other residues substitute for
the lack of a canonical active site motif) (Xu et al., 2000; Min
et al., 2004; Villa et al., 2009), (2) use alternative catalytic mech-
anisms to achieve phosphoryl-transfer or even developed
entirely different enzymatic activities (Mukherjee et al., 2008;
Shi et al., 2010; Sreelatha et al., 2018; Black et al., 2019), and
(3) fulfill important non-enzymatic functions including the allo-
steric regulation of active kinases or as scaffolds that tether inter-
acting partners to larger complexes (Scheeff et al., 2009; Zeqiraj
et al., 2009a; Bailey et al., 2015; Lavoie et al., 2018).
IRAK1 and IRAK4 are catalytically active members of the IRAK
family (Cao et al., 1996; Li et al., 2002; Motshwene et al., 2009;
Flannery andBowie, 2010). DD-mediated oligomerization ofmul-
tiple IRAK4 molecules induces trans-autophosphorylation of
IRAK4 at T345 and S346, which leads to an increase in IRAK1 ki-
nase activity, possibly due to allosteric activation of IRAK1
following binding to phosphorylated IRAK4 (Ferrao et al., 2014;
Vollmer et al., 2017). In contrast, IRAK2 and IRAK3 are thought
to be catalytically inactive pseudokinases as they both lack the
catalytic aspartate and other essential active site residues (Fig-
ure 1B) (Muzio et al., 1997; Wesche et al., 1999). Despite being
discovered more than two decades ago, the detailed roles of
the IRAK2 and IRAK3 pseudokinases are still largely unknown.
IRAK3 is expressed in several tissues and immune cells with
highest expression in myeloid cells (Wesche et al., 1999; Lizio
et al., 2015). Several lines of evidence suggest that IRAK3 is a
negative regulator of signaling, since there is an enhanced in-
flammatory response to bacterial infection and increased sus-
ceptibility to LPS-induced septic shock in IRAK3/ mice (Ko-
bayashi et al., 2002). However, many findings about the role of
IRAK3 need to be critically re-evaluated following the recent dis-
covery that a widely used IRAK3/ mice line may still express a
splice variant of IRAK3 (Rothschild et al., 2017) that lacks the C-
lobe of the pseudokinase domain and the TRAF6-binding region,
yet appears to strongly activate NF-kB-dependent gene
transcription.
Nonetheless, clinical data support a role for IRAK3 as a negative
regulator of innate immunity, as multiple mutations in IRAK3 have
been linked to the pathogenesis of early-onset persistent asthma
(Balaci et al., 2007) and high expression levels of IRAK3 and mu-
tations in the pseudokinase domain correlate with an increased
risk of cancer (Saenger et al., 2014; Kesselring et al., 2016). While
it is unclear how IRAK3 exerts its negative regulatory effects, these
findings highlight the potential of IRAK3 as a drug target in immu-
nodeficiency diseases and in cancer immunotherapies.
The crystal structures of the kinase domains of IRAK1 and
IRAK4 in complex with various ligands and inhibitors have pro-
vided valuable insights into their mechanisms of action (Wang
et al., 2006, 2017, 2019; Kuglstatter et al., 2007; Ferrao et al.,
2014). In contrast, no structures of the pseudokinase domains
of IRAK2 or IRAK3 have been reported to date, and hence their
functions and mechanistic details remain elusive.
Here we report the crystal structure of the pseudokinase
domain of human IRAK3 at 2.9 Å resolution, which reveals a
closed, pseudoactive conformation with an evolutionarily
conserved cysteine residue located in the regulatory spine (R-
spine). IRAK3 dimerizes in a pseudosymmetric ‘‘head-to-head’’
assembly with central aC-helices, stabilized by two disulfide
bridges. We further identify a conserved C-lobe surface on
IRAK3 that harbors asthma-associatedmutations and closely re-
sembles the previously reported IRAK4 homodimer interface.
We propose a model for hetero-oligomerization between
IRAK3 and IRAK4 via this C-lobal interface.
RESULTS
Sequence Analysis of IRAK3
Sequence alignment of the four human IRAK family members
with the canonical kinase PKA, revealed that the canonical
Figure 1. Domain Architecture and Active
Site Motifs of the IRAK Family
(A) Domain overview of human IRAK family members
with indicated domain boundaries. Death domains
(DD) in red, Pro-Ser-Thr-rich regions (PST) in yellow,
kinase domains and pseudokinase domains in blue,
and C-terminal TRAF6-binding regions in green.
(B) Sequence alignment of kinase active site motifs
in human IRAK family members and PKAwith critical
residues highlighted in color and deviations from
canonical motifs in gray. Below, the consensus
sequence of 134 IRAK3 orthologues in vertebrates
with polar residues in green, non-polar residues in
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kinase active site motifs are conserved in the catalytically active
familymembers, IRAK1 and IRAK4, but not in the pseudokinases
IRAK2 and IRAK3 (Figure 1B). While the residues of the G-loop
and KE-salt bridge are conserved in IRAK2, the catalytic aspar-
tate is replaced by an asparagine. Interestingly, the Mg2+-coor-
dinating ‘‘DFG’’-motif is changed to ‘‘HP,’’ which suggests an
unusual nucleotide-binding mechanism, as IRAK2 has been pre-
viously shown to bind ATP in aMg2+-dependentmanner (Murphy
et al., 2014). In the absence of an IRAK2 structure, we speculate
that the basic histidine residue may replace one of the twoMg2+-
ions in the ATP-binding pocket, reminiscent of the ATP-binding
mechanism of the Ca2+/calmodulin-activated serine/threonine
kinase (CASK) where an analogous histidine residue directly
binds ATP (Mukherjee et al., 2008).
IRAK3 is found throughout the vertebrata subphylum and a
conservation analysis of the primary sequences of 134 verte-
brate IRAK3 orthologues shows that several alterations to ca-
nonical kinase active site motifs are preserved throughout evolu-
tion (Figure 1B). The large aromatic phenylalanine (F177) residue
disrupts the G-loop motif at the position of the third glycine and
shows strong conservation. The canonical catalytic ‘‘HRD’’-
motif is missing entirely in IRAK3 and replaced with ‘‘CGS,’’
whereas the Mg2+-coordinating ‘‘DFG’’-motif is slightly altered
to ‘‘DFA.’’ Interestingly, the ‘‘CGS’’ sequence that replaces the
catalytic motif in IRAK3 is also well conserved at C291 and
G292, while the position of S293 is frequently occupied by S or
N residues in other vertebrates. The Mg-binding loop motif
also displays a strong conservation of D311 and F312, while po-
sition 313 is primarily occupied by either A or G. However, the
residues of the KE-salt bridge are conserved, as they are for all
human IRAK family members. These analyses indicate an evolu-
tionarily conserved function for the altered kinase active site res-
idues of IRAK3.
Crystal Structure of IRAK3 Reveals Closed
Conformation
To gain more insight into the functions of IRAK3, we crystallized
the pseudokinase domain (residues 145–454). The structure was
determined at 2.9 Å resolution by molecular replacement and
refined to the statistics shown in Table S1. The asymmetric
unit (ASU) contains 3 molecules of IRAK3. The structure reveals
that the eukaryotic kinase fold is conserved in the pseudokinase
domain of human IRAK3 (Figures 2A and 2B). The N-lobe con-
sists of an anti-parallel b-sheet formed by b-strands b1-b5,
which are flanked by the aA- and aC-helices. The atypical G-
loop of IRAK3 is located between b-strands b1 and b2. The
two lobes are bridged by a hinge-region formed by b7, b8 and
aD. The ‘‘catalytic’’-loop with the degenerate ‘‘CGS’’-motif of
IRAK3 connects b6 and b7, while the Mg-binding loop with the
‘‘DFA’’-sequence resides between b8 and b9. The remaining
C-lobe is made up of five tightly packed a-helices (aE, aF, aG,
aH and aI) and two short helical extensions (aEF and aGH).
In the crystal structure, IRAK3 adopts a pseudoactive confor-
mation that mimics the active state of canonical protein kinases.
The aC-helix of IRAK3 is in an inward-oriented position with an
intact KE-salt bridge formed by K192 of the b3-strand and E212
of the aC-helix. Superposition of IRAK3 with structures of active
and inactive forms of the archetypal kinase Cyclin-Dependent Ki-
nase 2 (CDK2) illustrates that IRAK3 closely resembles the active
conformation (Figure 2C). A recently introduced, improved
nomenclature to typify protein kinase conformations is based on
the conformation of the DFG motif, the Ramachandran regions
they fall in, the backbone dihedral angles of the residue preceding
the DFGmotif and the side chain rotamer of the Phe residue (Modi
and Dunbrack, 2019). Analyzing the equivalent ‘‘DFA’’ motif of
IRAK3 reveals that IRAK3 can be assigned to the BLAminus clus-
ter as residue T310, preceding the ‘‘DFA’’-sequence of IRAK3,
falls into the b-sheet region (B), D311 into the left-handed helical
region (L) and F312 into the a-helical region (A) of the Ramachan-
dran plot, while the side chain of F312 is close to a 60 rotamer
(‘‘minus’’). Interestingly, the DFG motif of most active protein ki-
nase conformations fall into the same ‘‘BLAminus’’ cluster. Struc-
tural superposition of the DFAmotif of IRAK3 with the Mg-binding
motif of another BLAminus cluster member, the b-subunit of the
insulin receptor kinase (IRb), presents a well-aligned peptide
backbone and phenylalanine side chain reflected by an all-atom
RMSD of 0.38 Å2 (Figure 2D).
Another hallmark of an active kinase conformation in IRAK3 is
the intact regulatory spine (R-spine) formed by L227, L216, F312,
C291, and L309 (Figure 2E). The first three R-spine residues of
IRAK3 (L227, L216, and F312) match the respective amino acids
of the canonical protein kinase PKA (L106, L95 and F185) with an
all-atom RMSD of 0.70 Å2 (Knighton et al., 1991). The position of
Y164 of PKA is occupied by two residues in IRAK3, C291 of the
conserved ‘‘CGS’’ sequence and L309, located in the adjacent
b8-strand. The presence of this evolutionarily conserved
cysteine residue in the R-spine of IRAK3 suggests the possibility
of a redox-based mechanism that controls R-spine assembly. In
this scenario, the modification or oxidation of C291 would pre-
vent R-spine assembly and thereby stabilize the open pseudoki-
nase conformation of IRAK3. Interestingly, a similar redox-based
mechanism has been recently shown to regulate the kinase ac-
tivity of Aurora A through reversible oxidation of a cysteine in
the activation segment (Byrne et al., 2020). In a sequence anal-
ysis of the human kinome we identified only one other protein
with a cysteine at this position, namely the poorly characterized
pseudokinase RPS6KC1 (Ribosomal protein S6 kinase delta-1).
Intriguingly, the structure of IRAK3 also revealed a pre-ar-
ranged catalytic spine (C-spine) deprived of ATP. The C-spine
is a hydrophobic network formed in an active conformation in ca-
nonical kinases, which spans from the central C-lobal aF-helix to
the b2-and b3-strands of the N-lobe and is completed by the
adenine ring of ATP (Kornev et al., 2008). Superposition of
IRAK3 and ATP-bound PKA in an active conformation shows
that IRAK3 has equivalent hydrophobic residues (V179, A190,
L249, I299, L300, L301, V363, and V367) positioned close to
the C-spine residues of PKA (V57, A70, M128, L172, L173,
I174, L227, and M231), although IRAK3 is not bound to ATP (Fig-
ure 2F). Since the C-spine is already pre-formed in the absence
of ATP, we predict that the ATP-bound form of IRAK3 would
likely adopt a similar conformation to the nucleotide-free
IRAK3 structure as no major structural rearrangements would
be necessary to complete the C-spine.
A Hydrophobic G-loop Anchor Stabilizes the Closed
Conformation in IRAK3
The G-loop of IRAK3 contains a degenerate motif of ‘‘GE-
GEIF’’, while the active family members, IRAK1 and IRAK4,
ll
OPEN ACCESSArticle
Structure 29, 1–14, February 4, 2021 3
Please cite this article in press as: Lange et al., Dimeric Structure of the Pseudokinase IRAK3 Suggests an Allosteric Mechanism for Negative Regu-
lation, Structure (2020), https://doi.org/10.1016/j.str.2020.11.004
both have ‘‘GEGGFG’’ at this position. Closer inspection of
the G-loop interactions in the IRAK3 structure revealed that
F177 anchors the G-loop to residues of the aC-helix, b3-and
b4-strands and to the Mg-binding loop (Figure 2G). F177
forms a hydrophobic network with the neighboring I176, with
K192 and F194 of the b3-strand, R208, F209, E212, and
L213 of the aC-helix, L239 of the b4-strand and A313 of the
Mg-binding loop, to stabilize an ordered G-loop. The hydro-
phobic anchor F177 thereby leads to a rigidification of the
Figure 2. Structure of the IRAK3 Pseudoki-
nase Domain
(A) Schematic representation of the eukaryotic pro-
tein kinase architecture.
(B) Crystal structure of the pseudokinase domain of
IRAK3 colored by secondary structure with a-heli-
ces in red, b-strands in blue, loops in gray and active
site loops in yellow. Dotted lines indicate flexible
loops without structural information.
(C) IRAK3 (blue) superposed with inactive (red, PDB
3PXF;Betzi et al., 2011) andactive (green, PDB3QHW;
Bao et al., 2011) conformations of CDK2. KE-salt
bridge residues are shown as stick models.
(D) DFAmotif of IRAK3 (blue) alignedwith DFGmotif of
IRb of BLAminus cluster (pink, PDB 3BU5; Wu et al.,
2008).
(E) Superposition of IRAK3 in blue and PKA in orange
(PDB 2CPK) with regulatory spine residues shown as
stick models.
(F) Superposition of IRAK3 in blue and PKA in orange
(PDB 2CPK) with catalytic spine residues shown as
stick models. ATP and Mg-ions are shown as semi-
transparent stick and sphere models, respectively.
Parts of the Mg-binding loops and aD-helices where
clipped for visibility.
(G) Interaction network formed by hydrophobic anchor
residue F177 (yellow) with surrounding residues in
IRAK3 (blue) shown as stickmodels. Gray-dotted lines
indicate distance measurements in Å.
G-loop and keeps the loop ordered in
the apo-form of IRAK3. This is in contrast
to the apo-structures of other protein ki-
nases, where the G-loop is typically
disordered and a ligand in the ATP-bind-
ing pocket is required to stabilize the
loop. The phenylalanine residue in this
position of the G-loop is evolutionarily
conserved in vertebrate IRAK3 ortho-
logues and appears to be unique within
the human kinome (Figure 1B). Interest-
ingly, analysis of the G-loop of the pseu-
dokinase MLKL reveals it to be similarly
stabilized in the absence of nucleotides
or inhibitors. While MLKL does not
possess an equivalent residue to the hy-
drophobic anchor F177 of IRAK3, the G-
loop of MLKL is instead stabilized by a
salt bridge formed between R210 of the
N-lobal b1-strand and E293 of the C-lo-
bal aD-helix (Figure 3A). In contrast, other
pseudokinases harbor more drastic alter-
ations that stabilize a specific conforma-
tion. The pseudokinase TRIB1, for example, has a severely
truncated G-loop and aC-helix while another pseudokinase,
VRK3, has multiple amino acid substitutions in the nucleo-
tide-binding pocket that not only block ATP-binding but also
lock the pseudokinase in a closed, pseudoactive conforma-
tion (Scheeff et al., 2009) (Figure 3B). In summary, IRAK3
adopts a closed pseudoactive conformation that is stabilized
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IRAK3 Has LowAffinity for ATP but High Affinity for ATP-
Competitive Inhibitors
The ATP-binding pocket of IRAK3 is unobstructed in the ligand-
free structure and superposition with IRAK4 revealed that most
residues involved in ATP-binding in IRAK4 are identical in
IRAK3, apart from L225 and E175 (Figure 4A). L225, which is
neighboring the tyrosine gatekeeper residue in IRAK3, protrudes
further into the ATP-binding pocket compared to V246, the
equivalent residue in IRAK4. Superposition of IRAK3 with
IRAK4 bound to the ATP-analogue Adenosine-5ʹ-[(b,g)-imido]-
triphosphate (AppNHp) indicates a steric clash of L225 of
IRAK3 with the 6-amino group of AppNHp (Figure 4B). While
the side chain of the E175 residue in the G-loop of IRAK3 does
not have fully defined electron density, chemical bond and Ram-
achandran restraints of the peptide backbone indicate the most-
favorable rotamer of E175 to protrude into the ATP-binding
pocket. Interestingly, superposition with AppNHp-bound
IRAK4 shows that the modeled E175 side chain is in close prox-
imity with the g-phosphate of AppNHp (Figure 4B). We predict
that the rigidification of the IRAK3 G-loop by the hydrophobic
F177 anchor further stabilizes the orientation of E175. Indeed,
similar aspartate-substitutions of G-loop residues have been
shown to cause negative charge repulsion between the phos-
Figure 3. Active Site Comparison between
IRAK3 and Other Pseudokinases
(A) Superposition of IRAK3 (blue) with the pseudo-
kinase MLKL (salmon, PDB 4WMI; Murphy et al.,
2014) and close-up view of the G-loop stabilizing
residues shown as stick models.
(B) Superposition of IRAK3 (blue) with the pseudo-
kinases TRIB1 (yellow, PDB 5CEM; Murphy et al.,
2015) and VRK3 (magenta, PDB 2JII; Scheeff et al.,
2009). Dotted circles indicate the severely altered
ATP-binding pockets of TRIB1 and VRK3.
phate- and carboxyl-groups and were
used to generate ATP-binding-deficient ki-
nase mutants (Zeqiraj et al., 2009a).
In contrast, superposition of IRAK3 with
IRAK4 bound to the pan-kinase inhibitor
staurosporine indicates no steric clashes
between staurosporine and IRAK3 (Fig-
ure 4C). The distance between L225 and
the closest atom of staurosporine is 2.8 Å,
while the carboxyl-group of E175 is 6.6 Å
away and not in range to interact with any
part of the staurosporine molecule.
Together, these observations suggest that
the ATP-binding pocket of IRAK3 might
be unfavorable for binding of ATP but
would allow staurosporine binding.
To test this prediction, we used thermal-
shift assays with the pseudokinase do-
mains of IRAK2 and IRAK3 following addi-
tion of MgCl2 (500 mM), ATP (50 mM),
MgCl2 and ATP (500 mM, 50 mM) or stauro-
sporine (10 mM) (Figures 4D and 4E). In
agreement with the structure-guided pre-
dictions, MgCl2 and ATP did not induce significant thermal shifts
in IRAK3, while the addition of staurosporine resulted in a +7.9C
shift of the melting temperature. In comparison, IRAK2 showed
robust thermal stabilization with both Mg-ATP and staurospor-
ine. These results are supported by a study that classified 31
different pseudokinase domains on the basis of their nucleo-
tide-binding behavior using thermal-shift assays, which reported
a lack of ATP-binding for IRAK3, but robust induction of thermal
shifts by the pan-kinase inhibitors VI16832 and DAP (Murphy
et al., 2014).
Intracellular ATP levels are typically in the mM concentration
range (Kennedy et al., 1999). We therefore performed a dose-
response analysis, where ATP concentrations were varied from
0 to 1.5 mM, to determine whether IRAK3 would bind ATP at
near physiological concentrations. Isothermal analysis of a se-
ries of thermal-shift assays with IRAK2 and IRAK3, revealed
that IRAK2 binds ATP with a Kd of 9.8 ± 3.8 mM at 45
C (Fig-
ure 4F), while IRAK3 is a weak ATP-binder with an estimated
Kd of 196 ± 19 mM at 45
C (Figure 4G). We have also confirmed
the weak ATP-binding affinity of IRAK3 using ITC and TNP-ATP
saturation binding experiments (data not shown). Collectively,
our results therefore suggest that the ATP-binding pocket of
IRAK3 may be nucleotide-bound at cellular ATP concentrations.
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IRAK3 Forms an Atypical Head-to-Head Dimer
We analyzed the arrangement of the three IRAKmolecules in the
ASU (chain IDs: A, B, C), which revealed that molecules A and B
form a dimer (A-B) (Figure 5A). Molecule C forms a dimer with a
symmetry-related molecule by a 2-fold rotation, C’ (C-C0) (Fig-
ure S2A). The dimers are formed via a pseudosymmetric
‘‘head-to-head’’ arrangement with the aC-helices as central ele-
ments of the dimer interface. The aC-helices are rotated by 97.2
clockwise against each other and form interactions with the aC-
helix, aE-b6-loop, b4-b5-loop and b9-strand of the opposing
molecule. Quaternary structure analysis revealed a buried sur-
face area of 955.6 Å2 and 1119.3 Å2 between the A-B and C-C0
dimers, respectively. The solvation free energy gain DiG upon
formation was calculated in QtPISA as 24.6 kcal/mol for the
A-B dimer and as 27.5 kcal/mol for the C-C0 dimer, with DiG
Figure 4. Nucleotide-Binding Analysis of
IRAK2 and IRAK3
(A–C) Superposition of ATP-binding pockets of
IRAK3 and (A) IRAK4 (PDB 2OID). (B) IRAK4-bound
ANP (PDB 2OID) and (C) IRAK4-bound Staur-
osporine (PDB 2OIC).
(D and E) Thermal shift assays of IRAK2192-507 (D)
and IRAK3145-454 (E) with buffer control (black),
500 mM MgCl2 (blue), 50 mM ATP (yellow), 50 mM
ATP +500 mMMgCl2 (green) or 10 mMStaurosporine
(red). Table lists induced thermal shifts.
(F and G) Thermal shift analaysis of IRAK2192-507 (F)
and IRAK3145-454 (G) at indicated ATP concentra-
tions and 5 mM MgCl2 and isothermal analysis of
ATP-dose response thermal shift assays at 45C.
Triplicate measurements, dissociation constants
(Kd) are shown with standard error of the mean.
p values of 0.030 and 0.007, respectively.
The large negative DiG values indicate a
strong positive protein affinity caused by
hydrophobic interactions, while the low p
values imply a high specificity of the inter-
faces and a low likelihood of being an arti-
fact of crystal packing. Interestingly, three
dimers (A-B, C-C0, A0-B0) assemble to
form a higher-order helical hexamer (B-A-
C-C0-A0-B0) in the crystal via C-lobal inter-
faces with central aG-helices between A-
C and C0-A0 molecules (Figure S2).
The head-to-head dimer interface of
IRAK3 is made up of a network of hydro-
phobic interactions with W206, L210,
L213, L217, L218, and F219 in the aC-helix
of one IRAK3 molecule interacting with
Y230 and T232 of the b5-strand, P286
and C287 of the aE-b6-loop, and F317 of
the b9-strand of the other IRAK3 molecule
in the dimer (Figures 5B and S3A). The
interface is flanked by two disulfide bonds
formed between C202 at the start of the
aC-helices and C287 of the aE-b6-loops.
Strikingly, E214 of both aC-helices is
located at the center of the interface at a
distance of 2.6 Å from each other, which
suggests hydrogen-bonding between the
carbonyl- and hydroxyl-groups of the opposing glutamate side
chains.
Conservation analysis of the aC-helix residues revealed that
many of the key residues of the head-to-head interface are highly
conserved through vertebrate evolution, including W206, L210,
L213, E214, L217, L218, and F219 (Figure S3B). One of the disul-
phide-bond forming cysteines, C287 in human IRAK3, is highly
conserved across vertebrates. In contrast, the position of the
other cysteine, C202, is less conserved but prefers cysteine
when present (Figure S3B). Intriguingly, most species that lack
the cysteine equivalent to C202, for example rodents and bony
fish, harbor an additional cysteine predicted to be within or close
to the head-to-head interface and might participate in disul-
phide-bridging. In rodents, an extra cysteine is located N-termi-
nal of the pseudokinase domain, while in bony fish, a cysteine is
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found at the position of human Y230 in the b5-strand that directly
contributes to the head-to-head dimer interface (Figure S3C). In
addition, the lack of cysteine residues in equivalent positions in
the other human IRAK family members suggests that disul-
Figure 5. IRAK3 Forms Homodimer in Solu-
tion and in Crystal Structure
(A) IRAK3 homodimer with monomers in blue and
yellow and highlighted regions that contribute to the
dimer interface. Arrows indicate orientation of aC-
helices fromN- to C-terminal residues (red to green).
(B) Close-up view of IRAK3 ‘‘head-to-head’’ dimer
with interface residues shown as stick models.
Dotted gray lines indicate distances with annotation
in Å.
(C) Analytical gel filtration chromatograms of
IRAK3145-454 wild-type (WT), L210E, and E214L
mutants in green, red and blue, respectively. Mo-
lecular mass standards in black with conalbumin
(75 kDa), ovalbumin (44 kDa) and carbonic anhy-
drase (29 kDa). Below, SDS-PAGE analysis of frac-
tions collected from analytical gel filtration runs and
molecular mass markers in far-right lane.
(D) Smooth surface and schematic representations
of kinase dimers of IRAK3, BRAF (PDB 3Q4C; Xie
et al., 2009), PKR (PDB 2A19; Dar et al., 2005), and
ErbB2 (PDB 3PP0; Aertgeerts et al., 2011). Mole-
cules A in light blue with aC-helices in dark blue,
molecules B in yellow with aC-helices in orange. N
and C indicate N-lobe and C-lobe, respectively.
Asterisks indicate location of ATP-binding pockets.
See also Figures S2 and S3.
phide-bond formation is specific for
IRAK3 and that IRAK3 dimerization could
be a redox-regulated event.
To validate the head-to-head dimers
observed in the crystal structure, we per-
formed analytical size exclusion chroma-
tography, which revealed that IRAK3 exists
in a dynamic equilibrium between mono-
meric and dimeric states under reducing
conditions (Figure S3D). Next, we intro-
duced structure-guided mutations in the
IRAK3 homodimer interface to confirm
that the in-solution dimer is identical to
the head-to-head dimer observed in the
crystal structure. We chose the central
L210 and E214 residues to generate
dimer-disrupting and dimer-stabilizing mu-
tations, respectively. The L210 residue of
one IRAK3molecule forms hydrophobic in-
teractions with the opposing IRAK3 via the
g- and d-carbons of E214 and the side-
chain of L218 (Figure 5B). We predicted
that a L210E substitution would break
these hydrophobic interactions and in
addition introduce a negative charge that
would repulse E214 of the opposing mole-
cule, thereby disrupting the IRAK3 dimer.
Conversely, we predicted the unusual
proximity of the two E214 residues in the dimer interface to be
energetically unfavorable due to Coulomb repulsion of the nega-
tively charged glutamate residues. Hence, the introduction of an
E214L mutation would remove the repulsive force and
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strengthen the hydrophobic interaction at the dimer interface,
thereby leading to a stabilization of the IRAK3 dimer.
To test these structure-based predictions, the dimerization
behavior of wild-type and mutant IRAK3 pseudokinase domains
were analyzed by analytical size exclusion chromatography (Fig-
ure 5C). The wild-type IRAK3 elutes as two peaks corresponding
to the dimeric and monomeric forms, respectively. The dimer-
disrupting L210E point-mutant of IRAK3 was observed as a
monomer, while the E214Lmutant eluted as a dimer. This exper-
iment therefore confirms that the head-to-head dimer, formed
between the IRAK3 molecules A-B and C-C0 in the crystal, is
identical to the dimer observed in solution. Further, the L210E
mutant was identified as a dimer-disrupting mutation and
E214L as a dimer-stabilizing point-mutant.
Importantly, the formation of the homodimer of IRAK3 is
distinct from the three different modes of dimerization
described previously to be involved in the allosteric regulation
of kinases through direct stabilization of the alpha-C helix (Fig-
ure 5D). The RAF family of kinases dimerize in a ‘‘side-to-side’’
fashion, while the eIF2a-related kinases form ‘‘back-to-back’’
dimers and the EGFR kinases are arranged as ‘‘head-to-tail’’
dimers (Lavoie et al., 2014). In comparison, the pseudokinase
RNase L forms ‘‘back-to-back’’ dimers (Han et al., 2014), while
the heterodimeric complex of the pseudokinase HER3 with
EGFR arranges in a ‘‘head-to-tail’’ fashion (Littlefield et al.,
2014). Outside of this classification, pseudokinases have
been observed to dimerize through adjacent N- or C-terminal
domains, as seen for the pseudokinase SgK223 (Patel et al.,
2017), through additional auxiliary proteins, as in the trimeric
complex of the pseudokinase STRADa with LKB1 and Mo25
(Zeqiraj et al., 2009b), or through kinase:substrate-like com-
plexes with interactions mainly through the C-lobal subdo-
mains, as reported for the MLKL-RIPK3 and KSR-MEK com-
plexes (Xie et al., 2013; Lavoie et al., 2018).The IRAK3 dimer
we identify here uses a previously unidentified interface
centered on the aC-helices, which represents a fourth mode
of ‘‘head-to-head’’ dimerization.
Asthma-Associated Mutations Locate to an
Evolutionarily Conserved Surface of IRAK3 that
Resembles the IRAK4 Homodimer Interface
Two of themutations in IRAK3 that are linked to the pathogenesis
of early-onset persistent asthma, L400V and R429Q, reside
within the pseudokinase domain and both locate to the C-lobe
(dbSNP ID: rs146120640 and rs140671957; Balaci et al., 2007).
L400 is located at the solvent interface of the aGH-helix and in-
teracts with the neighboring L396, L403, R412 and F419 resi-
dues (Figure 6A). The L400V mutation might therefore shift the
position of the aGH- and adjacent aG-helices. The R429 residue
is solvent exposed and located in the loop connecting the aH-
and aI-helices. The R429Q mutation would therefore change
the electrostatic surface potential of this region.
To gain insights into these disease-associated mutations, we
analyzed the surface conservation of human IRAK3 based on
sequence conservation in vertebrate IRAK3 orthologues, which
revealed regions of conservation that are not evident from the
primary sequence alone. Two conserved surface areas of
IRAK3 are the ATP-binding pocket and the head-to-head dimer
interface (Figure 6B and S4A). In addition, we identified a third re-
gion of high conservation in the C-lobe of IRAK3 between the
aEF- and aG-helices (Figure 6B). Strikingly, both residues of
the asthma-associated mutations in IRAK3 lie within or are
directly adjacent to this conserved surface. We further noticed
that the conserved C-lobe surface in IRAK3 closely resembles
the C-lobal homodimer interface of unphosphorylated IRAK4
(Figure 6C; PDB 4U97). Structural alignment of IRAK3 and
IRAK4 showed a conservation of surface charges of most resi-
dues at the center of this C-lobe interface (Figure 6D). Of note,
mutation of K440 to E in IRAK4, the residue equivalent to R429
in IRAK3, was shown to disrupt the IRAK4 homodimer (Ferrao
et al., 2014).
Based on these observations, we postulated that IRAK3 and
IRAK4 may interact via their pseudokinase and kinase domains
to form a higher-order IRAK3-IRAK4 complex. To further test
this possibility, we performed a native PAGE co-migration anal-
ysis with the kinase and pseudokinase domains of IRAK family
members (Figure 6E). The kinase and pseudokinase domains
of IRAK-1, -2, and -3 have basic theoretical isoelectric points
of 8 and therefore migrate slowly in a native gel at pH 8.8
(lane 1–3). In contrast, the kinase domain of IRAK4 is more acidic
with a theoretical isoelectric point (pI) of 5 and migrates more
rapidly during native PAGE in its unphosphorylated and phos-
phorylated (IRAK4-P) forms (lane 4–5).
We did not observe co-migration of unphosphorylated IRAK4
with any of the other IRAK family members (lane 6–8). However,
the kinase domains of IRAK1 and IRAK4-P did co-migrate, indi-
cating the formation of a stable complex (lane 9). This result
agrees with previous reports by Wang and colleagues who
showed co-migration of the kinase domain of IRAK1 with full-
length phosphorylated IRAK4 (Wang et al., 2017). Our findings
therefore establish that the kinase domains of IRAK1 and phos-
phorylated IRAK4 are sufficient for this complex to form, which
might underlie the proposed allosteric activation of IRAK1 by
IRAK4 (Vollmer et al., 2017). In contrast, IRAK2 did not co-
migrate with IRAK4-P (lane 10). In the case of IRAK3, elongated
bands of IRAK3 and IRAK4-P indicate a weak interaction that
causes IRAK3 to be dragged into the native gel, while delaying
migration of IRAK4-P (lane 11). This indicates the formation of
a transient complex between the pseudokinase domain of
IRAK3 and the phosphorylated kinase domain of IRAK4. Full-
length IRAK family members are thought to be recruited via their
N-terminal DDs into the oligomeric Myddosome complex
(Motshwene et al., 2009; Lin et al., 2010), leading to an increased
local concentration of the kinase and pseudokinase domains.
Within this complex, the transient interaction between IRAK3
and phosphorylated IRAK4, even if of weak affinity, may become
functionally relevant.
Structural superposition of the IRAK3 homodimer with IRAK4
homodimers revealed that the respective head-to-head and C-
lobal dimerization interfaces are not overlapping and could
therefore co-exist within one complex (Figure 7). This assembly
arranges the two kinase domains of IRAK4 in an anti-parallel
orientation to each other with compatible electrostatic surface
potentials (Figures 7 and S4B). Notably, this arrangement buries
the active sites of IRAK4 within the complex and it is tempting to
speculate that the pseudokinase domain of IRAK3might interact
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Strikingly, the aforementioned helical hexamer of IRAK3
formed in the IRAK3 crystal is also compatible with the C-lobal
IRAK4 interface. Superimposition of IRAK4 dimers onto each
monomer of the IRAK3 hexamer creates an oligomeric assembly
where IRAK4 molecules fill the center of the helical IRAK3 hex-
amer (Figure S4C). Importantly, the N- and C-termini of the pseu-
dokinase and kinase domains are solvent exposed in both
models of tetrameric and oligomeric assemblies and would
therefore be able to accommodate the additional N- and C-ter-
minal domains of full-length IRAK3 and IRAK4.
Figure 6. Evolutionarily Conserved Residues
and Disease-Associated Mutations of IRAK3
Locate to C-lobe and Superimpose to C-lobal
Dimer-Interface of IRAK4
(A) Location of IRAK3 mutations associated to early-
onset persistent asthma on pseudokinase domain.
(B) IRAK3 surface colored by conservation in verte-
brate orthologues from low (green) to high (red).
(C) IRAK4 homodimer (PDB 4U97) with molecule A
as green surface and oriented as IRAK3 in (B). The
second IRAK4 molecule B is shown as gray ribbon.
The dimer interface on molecule A is highlighted in
yellow.
(D) Superposition of IRAK3 (blue) and IRAK4 (green;
PDB 4U97) with close-up view of central C-lobal
dimer interface residues as stick models.
(E) Native PAGE co-migration analysis of the kinase
domain of IRAK4 and phosphorylated IRAK4
(IRAK4-P) with kinase and pseudokinase domains of
IRAKs-1, -2 and -3. Gel stained with Coomassie
Blue. Inputs are indicated above numbered lanes
and complexes of IRAK4-P with IRAK1 and IRAK3
are boxed by dotted lines.
DISCUSSION
Most canonical protein kinases can switch
between an active, closed conformation
and an unproductive, open conformation,
and employ various regulatory mecha-
nisms that control this transition (Kornev
et al., 2006; Endicott et al., 2012). A special
type of allosteric regulation of kinase activ-
ity is mediated by heterodimerization be-
tween kinases and pseudokinases. Like
their active kinase counterparts, many
pseudokinases have retained their ability
to bind ATP and to switch between open
and closed conformations (Boudeau
et al., 2006; Zeqiraj and van Aalten, 2010;
Dar, 2013). For example, ATP-binding to
the pseudokinase STRADa assists in stabi-
lization of a pseudoactive, closed confor-
mation, which in turn allows STRADa to
bind to and activate the LKB1 kinase (Ze-
qiraj et al., 2009a). Here, we find that
IRAK3 has a weak affinity for ATP, despite
having a mostly unobstructed ATP-binding
pocket that is accessible for the ATP-
competitive inhibitor staurosporine. The
only other pseudokinase described to have similar binding
behavior is the JH2 pseudokinase domain of TYK2, which has
a low affinity for ATP, but is still capable of binding to ATP-
competitive inhibitors (Murphy et al., 2014; Min et al., 2015).
This characteristic of IRAK3 makes it an attractive candidate to
develop potent inhibitors that would compete successfully with
the high intracellular ATP levels present in vivo. Such inhibitors
could either stabilize the closed conformation or destabilize it
to affect the downstream signaling events that IRAK3 regulates.
A similar approach has been established for small molecules that
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disrupt the conformation of the pseudokinase ROR1 (Sheetz
et al., 2020). Alternatively, inhibitors could be used to develop
PROTACs for targeted degradation, as has been demonstrated
recently (Degorce et al., 2020).
The IRAK3 structure revealed an evolutionarily conserved
cysteine in the R-spine that stabilizes the closed conformation.
This suggests that the conformation of IRAK3 might be regu-
lated by a redox-based mechanism, where oxidation or another
modification of this cysteine would prevent R-spine assembly,
thereby preserving an open conformation. The presence of
two disulfide bridges that stabilize the interface of the head-
to-head dimer of IRAK3 suggests that IRAK3 might be addition-
ally subject to redox-regulation. Indeed, reactive nitrogen and
oxygen species are reported to have dual roles in innate immu-
nity by acting as immunotoxins and modulators of immune
signaling (Van Dervort et al., 1994; Jacobs and Ignarro, 2003;
Grumbach et al., 2005; Li and Engelhardt, 2006; Wink et al.,
2011). Direct regulation of protein kinases by thiol-modifica-
tions has been reported for a number of kinases and the high
prevalence of cysteine residues in kinase active sites suggests
that it is a commonly used to regulate this ‘‘cysteinome’’ sub-
section of the kinome (Byrne et al., 2017). Redox-mediated
inactivation through modifications of cysteines in the activation
segment has been reported for the IKK complex (Reynaert
et al., 2006) and more recently for the kinase Aurora A (Byrne
et al., 2020). Similarly, redox-mediated activation and inactiva-
tion of kinases through intermolecular disulphide-bond forma-
tion has been shown for PKA (Brennan et al., 2006) and fructos-
amine-3-kinases (Shrestha et al., 2020), respectively. Our data
suggest that IRAK3 may respond to changes in redox levels in
two ways: (1) to transition from a closed to an open conforma-
tion through modification of the conserved R-spine cysteine,
Figure 7. Model of Putative IRAK3-IRAK4
Hetero-Oligomerization
Center top: Superposition of IRAK3 dimer and
IRAK4 (PDB 4U97) with C-lobal interface between
IRAK3 and IRAK4 molecules in blue/purple and
green/dark green, respectively. Model rotated by
90 along z axis to the left and right. Arrows and
yellow dotted circle indicate interaction interfaces
and occluded IRAK4 active sites, respectively.
Below, schematic representation of hetero-tetra-
meric assembly with N- and C-lobes indicated as N
and C. Location of IRAK4 active site is marked by a
yellow star. See also Figure S4.
and (2) to stabilize the dimeric state by
forming two disulfide bonds across the
dimer interface. Further research is
needed to validate and evaluate the
redox-sensitivity of IRAK3 and its effects
on downstream signaling.
The IRAK3 dimer has a head-to-head
dimerization interface, distinct from the
three modes of kinase dimerization
described previously (Lavoie et al., 2014).
The unique interdependent packing of the
two aC-helices in the IRAK3 dimer stabi-
lizes the closed conformation. Such stabili-
zation has been observed previously for both kinases and pseu-
dokinases. For example, binding of cyclin A to the kinase Cdk2
leads to its activation due to conformational rearrangements in
the active site when cyclin A docks on to the aC-helix of Cdk2.
In the absence of cyclin A, the aC-helix is displaced, its hydro-
phobic spine is broken and Cdk2 remains inactive (Jeffrey
et al., 1995; Endicott et al., 2012).
Homo- and heterodimerization with other kinases or pseudo-
kinases is a specialized form of kinase regulation, which has
been observed in many kinases. It is typically mediated by
trans-phosphorylation events, where one kinase phosphory-
lates the activation loop of the other, or via an allosteric mech-
anism in which an inhibitory element is displaced or the active
site remodeled into a catalytically functional state (Endicott
et al., 2012; Lavoie et al., 2014). The homo- and heterodimeri-
zation of the kinase domains of IRAK1 and IRAK4 has emerged
as an important way in which the Myddosome initiates signal
transduction (Kuglstatter et al., 2007; Ferrao et al., 2014;
Wang et al., 2017). The unphosphorylated kinase domain of
IRAK4 forms a dimer that is primed for trans-autophosphoryla-
tion, an event that is induced by Myddosome assembly in cells.
Once IRAK4 is autophosphorylated, the IRAK4 homodimer dis-
sociates (Ferrao et al., 2014; Wang et al., 2019) and indeed the
phosphorylated IRAK4 kinase domain was crystallized as a
monomer (Kuglstatter et al., 2007). The kinase domain of
IRAK1 forms a stable complex with autophosphorylated full-
length IRAK4 (Wang et al., 2017) and we showed here that
the phosphorylated kinase domain of IRAK4 is sufficient for
this interaction.
The model of IRAK3-IRAK4 hetero-oligomerization we pro-
pose here reveals surprisingly compatible interfaces between
IRAK3 and IRAK4, as well as an anti-parallel arrangement of
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IRAK4 molecules that occludes the active site. Importantly, such
hetero-oligomeric assembly would be functionally relevant as
IRAK4 activity would be inhibited by its interaction with IRAK3 di-
mers. Although this hypothesis is unproven, our findings lay the
foundation for amore detailed analysis of the function of IRAK3 in
IL-1R/TLR-signaling, which is still unclear. Interestingly, although
IRAK3 expression is low in non-immune cells, it is expressed at
similar levels to IRAK4 in mouse bone marrow-derived macro-
phages and at far higher levels than IRAK1 and IRAK2 (JSC
Arthur, Personal Communication, 2020; Figure S4D). IRAK3
and IRAK4 are therefore likely to be major components of Myd-
dosomes in these immune cells. Further studies of the interac-
tions between the kinase and pseudokinase domains of IRAKs
will be needed to understand how they regulate each other.
We believe that the high concentration of IRAKs 3 and 4 in Myd-
dosomes is likely to favor interactions between their kinase and
pseudokinase domains, enabling IRAK3 to modulate the even-
tual signaling outcome.
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PreScission Protease (GST tagged) MRC PPU Reagents Cat#GNNYH4
IRAK4 1 - 460 MRC PPU Reagents Cat#AAH13316
Experimental Models: Organisms/Strains




MRC PPU Reagents Cat#DU56583
6His-TEV-GST-3C-AVI-IRAK2 192-507 MRC PPU Reagents Cat#DU56367
6His-TEV-GST-3C-IRAK3 145-454 MRC PPU Reagents Cat#DU56013
6His-TEV-GST-3C-IRAK3 145-454 L210E MRC PPU Reagents Cat#DU29610
6His-TEV-GST-3C-IRAK3 145-454 E214L MRC PPU Reagents Cat#DU65135
6His-TEV-GST-3C-AVI-IRAK4 160-
460 D329A
MRC PPU Reagents Cat#DU56578
Deposited Data
IRAK3 This paper PDB 6RUU
PKA ((Knighton et al., 1991) PDB 2CPK
IRAK4 - AppNHp (Kuglstatter et al., 2007) PDB 2OID
IRAK4 - Staurosporine (Kuglstatter et al., 2007) PDB 2OIC
IRAK4 – asymmetric dimer (Ferrao et al., 2014) PDB 4U97
BRAF (Xie et al., 2009) PDB 3Q4C
PKR (Dar et al., 2005) PDB 2A19
ErbB2 (Aertgeerts et al., 2011) PDB 3PP0
CDK2 - ANS (Betzi et al., 2011) PDB 3PXF
CDK2 - PKTPKKAKKL (Bao et al., 2011) PDB 3QHW
IRb – Mg-ATP (Wu et al., 2008) PDB 3BU5
(Continued on next page)
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RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Yogesh
Kulathu (y.kulathu@dundee.ac.uk).
Materials Availability
Generated cDNA clones are listed in the Key Resources Table and are available through MRC PPU Reagents and Services (https://
mrcppureagents.dundee.ac.uk/).
Data and Code Availability
The accession number for the coordinates and structure factors of the IRAK3 pseudokinase domain reported in this paper is
PDB: 6RUU.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All IRAK proteins were produced by expression in Sf21 insect cells (Invitrogen, Cat#11497013). Bacmid DNA was generated by
transformation of pFastBac vectors into DH10B EMBacY cells and used for baculovirus generation and amplification in Sf21
cells as previously described (Craig and Berger, 2011). Transformed DH10EMBacY (Geneva Biotech) were grown overnight
at 37C on LB agar supplemented with 10 mg/ml gentamicin, 50 mg/ml kanamycin, 10 mg/ml tetracycline, 0.2 mg/ml Xgal
and 1 mM IPTG for blue-white selection. Single white colonies were used to inoculate 5 ml LB medium supplemented with
10 mg/ml gentamicin and 50 mg/ml kanamycin and incubated at 37C and 180 rpm shaking overnight. Sf21 insect cells were
cultured in Sf-900 II serum-free medium (Thermo Fisher Scientific, Cat# 10902096) at 27C. Sf21 cells were grown as
adherent culture for bacmid transfection and initial virus amplification, and as suspension cultures (110 rpm shaking) for further
virus amplification and protein expression.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
MLKL (Murphy et al., 2014b) PDB 4WMI
TRIB1 (Murphy et al., 2015) PDB 5CEM
VRK3 (Scheeff et al., 2009) PDB 2JII
Software and Algorithms
XDS (Kabsch, 1993) xds.mpimf-heidelberg.mpg.de
POINTLESS (Evans, 2006) www.ccp4.ac.uk
AIMLESS (Evans and Murshudov, 2013) www.ccp4.ac.uk
autoPROC (Vonrhein et al., 2011) www.globalphasing.com
STARANISO server (Tickle et al., 2016) www.globalphasing.com
Phenix software suite (Afonine et al., 2012) www.phenix-online.org
BALBES (Long et al., 2008) www2.mrc-lmb.cam.ac.uk/groups/
murshudov/content/balbes/
documentation_fs/man_layout.html#install
MoRDa (Vagin and Lebedev, 2015) www.ccp4.ac.uk
COOT (Emsley et al., 2010) www2.mrc-lmb.cam.ac.uk/personal/
pemsley/coot/
PyMOL Schrödinger, LLC Pymol.org
QtPISA (Krissinel, 2015) www.ccp4.ac.uk
Clustal Omega (Goujon et al., 2010) www.ebi.ac.uk/Tools/msa/clustalo/
WebLogo server (Crooks et al., 2004) weblogo.berkeley.edu
ConSurf server (Ashkenazy et al., 2016) consurf.tau.ac.il
Other
AKTA pure 25 GE Healthcare Cat#29-0211-97
Superdex Increase 75 3.2/300 GL GE Healthcare Cat#29-1487-23
HiLoad 16/600 Superdex 75 pg GE Healthcare Cat#28-9893-33
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METHOD DETAILS
Baculovirus Generation and Protein Production
Expressionculturesofbaculovirus-infectedSf21wereshakenat120 rpmfor 72-96hat27Cuntil thepercentageofYFP-expressingcells
reached >80%. At this point, cells were harvested by centrifugation at 2000 g and 4C for 30min. Cell pellets were resuspended in ice-
cold lysis buffer (50mMHEPES pH 7.5, 500mMNaCl, 20%glycerol, 1 mMAEBSF, 1 mMbenzamidine, 5 mM2-mercaptoethanol) and
lysed by 30 passes in a Dounce homogeniser on ice. Cell debris was removed by centrifugation at 30,000 g and 4C for 30min. Ice-cold
buffer A (50mMHEPESpH7.5, 500mMNaCl, 20%glycerol, 5mM2-mercaptoethanol) was used for resin equilibration andwash steps
during subsequent tandem-affinity purifications. IRAKproteinswerepurified by an initial pass overNi-NTA resin, to remove endogenous
GSH-binding proteins, and subsequent purification on GSH 4B sepharose. The protein was eluted from GSH-resin by cleavage of the
6His-GST-tagwithPreScission protease at 4C for 4-16 h. Finally, proteinswere cleaned up in a gel filtration runwith aHigh LoadSuper-
dex 75 pg 16/600 column equilibrated with buffer B (20 mM HEPES pH 7.5, 300 mM NaCl, 10% glycerol, 1 mM DTT).
Analytical Size Exclusion Chromatography
Analytical gel filtration runs were performed on a Superdex Increase 3.2/300 column (GE Healthcare) equilibrated with 20mMHEPES
pH 7.5, 200 mMNaCl, 10% glycerol, 1 mMDTT. Sample were loaded in 25 ml volumes at 1-5 mg/ml concentrations. Elution fractions
were analysed by SDS-PAGE and stained with Coomassie blue.
X-ray Crystallography and Structural Analysis
Small crystal clusters of IRAK3 were initially observed in the commercial crystal screen AmSO4 Suite (Qiagen) and manually opti-
mised to obtain single, diffraction-quality crystals. The best crystallisation results were achieved by mixing 3 mL of purified
IRAK3145-454, concentrated to 7-10 mg/mL, with 1.5 mL of crystallisation cocktail containing 0.1 M citric acid pH 5.0 and 1.62 M
ammonium sulfate (2:1 drop ratio) and streak seeding. A crystal seed stock was obtained by mixing five 3 ml drops containing small
IRAK3 crystals with 50 mL of crystallisation cocktail, followed by vortexing for 30 s in a ‘Seed Bead’ tube (Hampton Research) to crush
the crystals. Crystal seedswere diluted 1:1000 in crystallisation cocktail and introduced using a ‘Seeding tool’ (Hampton Research) in
a smooth motion. After seeding, the drops were incubated at 20C in hanging drop plates with 1.0 ml reservoir volume and crystals
typically appeared within two days and reached maximum size in 5-7 days. This procedure yielded single rod-shaped crystals with
dimensions of up to 50x50x200 mm alongside multi-crystal clusters.
The IRAK3 crystals displayed relatively weak and anisotropic diffraction properties and themajority of the tested crystals diffracted
in the range of 5-8 Å. As estimated by the Matthews coefficient, the IRAK3-PK crystal had a relatively high solvent content of70%.
IRAK3 crystals that diffracted to 2.9 Å were soaked for 16 h in crystallisation cocktail containing 5mMethyl mercury phosphate (EMP)
and 30% glycerol before mounting on a nylon-loop and vitrification in liquid nitrogen. Diffraction data was collected at the i24 beam-
line at the Diamond Light Source, UK. All tested IRAK3 crystals consistently displayed anisotropic diffraction properties.We therefore
processed the diffraction data with XDS (Kabsch, 1993), AIMLESS (Evans and Murshudov, 2013) and POINTLESS (Evans, 2006) fol-
lowed by anisotropic processing with the Staraniso server (staraniso.globalphasing.org; Tickle et al., 2016) with directional resolution
cut-offs determined by local mean I/s(I) R 1.2 as 2.9 Å, 3.2 Å and 4.1 Å along the reciprocal c-, a-, and b-axes, respectively.
The IRAK3 structure was determined by molecular replacement in BALBES (Long et al., 2008) using a search model generated in
MoRDa (CCP4 online) (Vagin and Lebedev, 2015) from the protein kinase Pto fromSolanumpimpinellifolium, the currant tomato (PDB
ID: 2QKW) (Xing et al., 2007). The model was manually build and refined using COOT (Emsley et al., 2010) and phenix.refine (Afonine
et al., 2012). Quaternary structure analysis of the IRAK3 interfaces was performed with QtPisa (Krissinel, 2015). Structural super-
position and visualisations were created in PyMOL (Schrödinger, LLC) and electrostatic surface potential were generated with the
APBS tool 2.1 plugin (Baker et al., 2001).
Thermal Shift Assays and Isothermal Analysis of Thermal Shift Data
The target proteins were prepared in 10 ml volumes at 2.5 mM in 20 mM HEPES pH 7.5, 200 mM NaCl, 10% glycerol, 1 mM DTT, 3x
SYPRO orange dye and additives on ice subsequently heated in a temperature ramp of 1C/min from 5C to 75Cwhile recording the
FRET channel using a CFX384 real-time PCR detection system (BioRad). Thermal shift data was analysed using the ‘DSF analysis
v3.0’ Excel script as published by the Structural Genomics Consortium, Oxford (Niesen et al., 2007) and the Boltzmann sigmoidal
fitting function in GraphPad Prism v8.0. Isothermal analysis was performed with the ‘DSF fitting’ python program (Bai et al.,
2019). The change in heat capacity upon unfolding DCp was estimated as 4.03 and 4.27 kcal/K*mol for the pseudokinase domains
of IRAK2 and IRAK3, respectively. DCp estimation was based on the change in the solvent accessible surface area of nonpolar res-
idues between the folded and unfolded states DASA (Figure 3 in Novokhatny and Ingham, 1997). The ASA of folded states of IRAK2
and IRAK3 were calculated in PyMOL using a computational model of IRAK2 generated by one-to-one threading with IRAK4 (PDB
4U97) in Phyre2 (Kelley and Sternberg, 2009) or chain A of the IRAK3 structure, respectively. The ASA of unfolded states were esti-
mated from the primary amino acid sequence with theoretical ASA of individual amino acids (Table 1 in Tien et al., 2013).
Multiple Sequence Alignment and Conservation Analysis
Sequences of IRAK3 vertebrate orthologues were retrieved from OrthoDB (Kriventseva et al., 2015) and manually purged for dupli-
cates within species and sequences lacking the pseudokinase domain in JalView (Waterhouse et al., 2009). Sequences of all human
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kinase domains were retrieved from KinBase (Manning et al., 2002). Sequences were aligned by multiple sequence alignment using
Clustal Omega (Goujon et al., 2010) and analysed for spatial conservation by the ConSurf server (Ashkenazy et al., 2016). Sequence
conservations were visualised using the WebLogo server (Crooks et al., 2004).
Native PAGE Co-migration Assay
Continuous native PAGE 10% acrylamide gels were prepared by polymerisation of 375 mM Tris/HCl pH 8.8, 10% acrylamide (w/v),
0.01% (w/v) ammonium persulfate (APS) by the addition of 0.01% (v/v) TEMED. IRAK4 samples were phosphorylated in vitro by in-
cubation of IRAK4160-460
D329A with 1.5 U active full-length IRAK4 per mg of substrate in the presence of 2 mM ATP, 5 mMMgCl2 and
2.5mMDTT for 2.5 h at 30C. All native PAGE samples were prepared at a concentration of 1mg/ml per protein and pre-incubated on
ice for 1 h prior to loading. The gels were mounted in a gel running tank with SDS-free native PAGE running buffer (25 mM Tris,
192 mM glycine, pH 8.3). 10 ml sample volumes were loaded and separated by application of a constant electric current of 10 mA
for 2 h on ice and stained with Coomassie blue.
QUANTIFICATION AND STATISTICAL ANALYSIS
Thermal shift assays were conducted in triplicate and isothermal analysis was performed with the ‘DSF fitting’ python program (Bai
et al., 2019). The binding constants and standard errors were determined by fitting the data using GraphPad Prism (v8.4.2) as
described in Bai et al., 2019 to a nonlinear regression model (Y = 1 / (1 + (1 / Ku) * (1 + (((X - P - Kd *(1 + Ku) + (((P – X + Kd * (1 +
Ku))^2 + 4 * (X * Kd + X * Kd * Ku))^0.5)) / 2) / Kd))), where Y is the fraction of unfolded protein, X is the ligand concentration, Kd is
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